A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
Abroad (travel likely)RecruitingPHASE1
Conditions
Stable Coronary Artery Disease · Healthy Volunteers
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
ICON Plc (LPRA) - Netherlands, Groningen, Netherlands
Study leads
Clinical Trials
Study Director
Hoffmann-La Roche